UroOnco24
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
UroOnco24
Jun 30, 2024, 16:16 |
Blog
Gianluca Giannarini: Great joint ESUI - EAU Section Urological Imaging session
Gianluca Giannarini, Associate Editor of European Urology, Full Board Member of the EAU Guidelines Office, shared…
Jun 26, 2024, 14:55 |
Blog
Sarah P. Psutka: Grateful to be part of this incredible international community of UroOncs
Shilpa Gupta shared a post by Sarah P. Psutka, Associate Editor at European Urology, on X: "Thanks Morgan…
Jun 26, 2024, 13:04 |
Blog
Shilpa Gupta: Discussing GU Cancers at UroOnco24
Shilpa Gupta shared a post on X: “At Urology Oncology 2024 with a great group of…
Jun 26, 2024, 05:17 |
Blog
Sarah P. Psutka: Phenomenal session on key topics in Penile Cancer at UROonco24
Sarah P. Psutka, Assistant Professor of Urology at the University of Washington, shared on X:…
Jun 24, 2024, 23:40 |
Blog
Jeremy Teoh: What a wonderful UROonco24 meeting at Budapest!
Jeremy Teoh, Assistant Dean (External Affairs) & Associate Professor at CUHK Medicine, made the following…
Jun 24, 2024, 22:30 |
Blog
Sarah P. Psutka: Phenomenal program at UROonco24 meeting in stunning Budapest!
Sarah P. Psutka, Assistant Professor of Urology at the University of Washington, shared on X:…
Jun 23, 2024, 17:14 |
Blog
Sarah Psutka: A masterclass across the spectrum of bladder cancer at UROonco24
Sarah Psutka, Urologic Oncologist, Associate Professor at University of Washington School of Medicine, shared on…
Apr 21, 2024, 07:20 |
Blog
Rana McKay: UroOnco24 meeting in São Paulo
Rana McKay, GU Medical Oncologist at UC San Diego, shared on X: "At the UroOnco24…
All:
8
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube